Omega-3 Use in Psychiatry: Evidence-Based or Elegance-Based?
Affiliations
Affiliations
- a Kuwait Centre for Mental Health , Al-Manara CAP Centre , Shuwaikh , Kuwait.
Abstract
Use of omega-3 in psychiatric practice is on the rise. It has been used in diverse indications, notably mood disorders, schizophrenia, dementia, borderline personality, and neurodevelopmental disorders, with varying levels of evidence base. Here, the author sheds some light on the therapeutic potential of omega-3 as an appealing addition to psychopharmacological armamentarium.
Keywords: omega-3; psychiatric use.
Similar articles
Omega-3 fatty acids in psychiatry: a review.
Freeman MP.Ann Clin Psychiatry. 2000 Sep;12(3):159-65. doi: 10.1023/a:1009069002816.PMID: 10984006 Review.
Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry.
Freeman MP, Hibbeln JR, Wisner KL, Davis JM, Mischoulon D, Peet M, Keck PE Jr, Marangell LB, Richardson AJ, Lake J, Stoll AL.J Clin Psychiatry. 2006 Dec;67(12):1954-67. doi: 10.4088/jcp.v67n1217.PMID: 17194275 Review.
Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid?
Ross BM, Seguin J, Sieswerda LE.Lipids Health Dis. 2007 Sep 18;6:21. doi: 10.1186/1476-511X-6-21.PMID: 17877810 Free PMC article. Review.
Psychopharmacology of borderline personality disorder.
Raj YP.Curr Psychiatry Rep. 2004 Jun;6(3):225-31. doi: 10.1007/s11920-004-0068-y.PMID: 15142476 Review.
Psychopharmacology in child and adolescent psychiatry: a review of the past five years.
Campbell M, Spencer EK.J Am Acad Child Adolesc Psychiatry. 1988 May;27(3):269-79. doi: 10.1097/00004583-198805000-00001.PMID: 3288611 Review. No abstract available.
Cited by
Bersani FS, Mellon SH, Lindqvist D, Kang JI, Rampersaud R, Somvanshi PR, Doyle FJ, Hammamieh R, Jett M, Yehuda R, Marmar CR, Wolkowitz OM.Mil Med. 2020 Jan 7;185(Suppl 1):311-318. doi: 10.1093/milmed/usz260.PMID: 32074311 Free PMC article.